Skip to content

Efficacy of Repetitive Transcranial Magnetic Stimulation in Treating Refractory Obsessive Compulsive Disorder

Efficacy of Repetitive Transcranial Magnetic Stimulation in Treating Refractory Obsessive Compulsive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308041743N11
Enrollment
21
Registered
2013-11-05
Start date
2013-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory obsessive compulsive disorder. Mixed obsessional thoughts and acts

Interventions

Device: repetitive magnetic stimulation(rTMS) 750 total pulse stimulation at 20 Hz will be delivered with 25 train of 1.5 second duration at 100% of threshold. Bilaterally(right and left) Sham stimul

Sponsors

Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: •voluntary and competent to consent based on their ability to provide a spontaneous narrative description of the key elements of the study •have a Structured Clinical Interview for DSM-IV (SCID) confirmed diagnosis of OCD •are between the ages of 18 and 65 •have failed to achieve a clinical response, or did not tolerate, at least 3 separate antidepressant trials of sufficient dose (included clomipramine) and CBT for at least 10 weeks •have a score of greater than or equal to 17 on the Y-BOCS. A careful medical and neurological history will be taken to ensure that subjects have no unstable conditions that would preclude them from entering into the study. This history will focus on conditions such as seizures, neurologic, other medical problems and presence of metal implants Exclusion Criteria: •have a history of DSM-IV substance dependence in the last 6 months, and have DSM-IV substance abuse in the last month •have a concomitant major unstable medical or neurologic illness or have had a history of seizures •acutely suicidal •are pregnant •have metal implants. With respect to concomitant medications, patients will be excluded if they are currently (or in the last 4 weeks) taking: (a) more than lorazepam 2 mg daily (or equivalent), (b) monoamine oxidase inhibitors, (c) and/or bupropion due to its associated increased risk for seizures.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement rate of refractory OCD. Timepoint: after 10th, 20th sessions of rTMS or sham. Method of measurement: CGI ? YBOCS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Shaygan Fard

Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science

mshayganfard@yahoo.com+98 81 1827 4192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026